|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Involvement of PI3K/ Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation : a target for cancer chemotherapy 显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 2 | Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | STEELMAN L S NAVOLANIC P M SOKOLOSKY M L | 2008 | Oncogene2008，27，29： | 1 |
| 3 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy显示文摘 | CHANG F LEE J T NAVOLANIC P M | 2003 | Leukemia2003，17，3： | 1 |
| 4 | Involvement of P13K/Akt pathway in cell cycle progression,apoptosis,and neoplastic transformation:a target for cancer chemotherapy显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 5 | Involvement of PI3K/Akt pathway in cell cycle progression,apoptosis,and neoplastic transformation:a target for cancer chemotherapy显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 6 | Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | STEELMAN L S NAVOLANIC P M SOKOLOSKY M L | 2008 | Oncogene2008，27，29： | 1 |
| 7 | EGFR family signaling and its association with breast cancer development and resistance to chemotherapy显示文摘 | NAVOLANIC P M STEELMAN L S McCUBERY J A | 2003 | Int J Oncol2003，22，2： | 1 |
| 8 | Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | Steelman L S Navolanic P M Sokolosky M L | 2008 | Oncogene2008，27，29： | 1 |
| 9 | Involvement of PI3K/ Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation; a target for cancer chemotherapy显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 10 | Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | STEELMAN L S NAVOLANIC P M SOKOLOSKY M L | 2008 | Oncogene2008，27，29： | 1 |
| 11 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 12 | Elitek-rasburicase:an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome,a meeting report,Dallas,Texas,January 2002显示文摘 | NAVOLANIC P M PUI C H LARSON R A | 2003 | Leukemia2003，17，3： | 1 |
| 13 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy 显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 14 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy 显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
| 15 | Suppression of PTEN function increases breastcancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors显示文摘 | STEELMAN L S NAVOLANIC P M SOKOLOSKY M L TAYLOR J R LEHMANN B D CHAPPELL W H ABRAMS S L WONG E W STADELMAN K M TERRIAND M LESLIE N R MARTELLI A M STIVALA F LIBRA M FRANKLIN R A MCCUBREY J A | 2008 | Oncogene2008，27，29： | 1 |
| 16 | Elitek-rasburicase:an effective means to prevent and reat hyperuricemia associated with tumor lysis syndrome,a Meeting Report,Dallas,Texas,January 2002显示文摘 | NAVOLANIC P M PUI C H LARSON R A | 2003 | Leukemia2003，17，3： | 1 |
| 17 | Involvement of PI3-IGAkt pathway in cell cycle progression apoptosis, and neoplastic transformation: a target for cancer chemotherapy显示文摘 | CHANG F LEE J T NAVOLANIC P M | 2003 | Leukemia2003，17，3： | 1 |
| 18 | Involvement of PI3K/Akt pathway in cell cycle ' progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy 显示文摘 | CHANG F LEE J T NAVOLANIC P M | 2003 | Leukemia2003，17，3： | 1 |
| 19 | Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy 显示文摘 | Chang F Lee J T Navolanic P M | 2003 | Leukemia2003，17，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员